UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004011
Receipt No. R000004820
Scientific Title Multicenter Phase II sequential study of S-1/Oxaliplatin (SOX) and Bevacizumab as first line therapy followed by S-1/Irinotecan (IRIS) and Cetuximab as second line in patients with metastatic colorectal cancer. : A SOBIC study
Date of disclosure of the study information 2010/08/20
Last modified on 2020/08/17 12:56:55

No. Disposal Last modified on Item of update
1 Insert 2010/08/06 18:10:04
2 Update 2010/08/06 18:23:08 Condition
Condition
3 Update 2020/08/13 13:17:03 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
TEL
Email

Last name of contact person

Last name of contact person
Zip code
Address
Address
TEL
Name of primary sponsor
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
Organization
Organization
Address
Address
Tel
Email
4 Update 2020/08/17 10:10:04 Date of IRB
Last follow-up date
5 Update 2020/08/17 11:55:00 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
6 Update 2020/08/17 12:56:55 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.